Teva Pharma Stock Forward View - Simple Exponential Smoothing
| TEVA Stock | USD 33.07 0.14 0.42% |
Teva Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Teva Pharma stock prices and determine the direction of Teva Pharma Industries's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Teva Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
The value of RSI of Teva Pharma's share price is above 70 at this time. This usually implies that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Teva, making its price go up or down. Momentum 70
Buy Stretched
Oversold | Overbought |
Using Teva Pharma hype-based prediction, you can estimate the value of Teva Pharma Industries from the perspective of Teva Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Teva Pharma Industries on the next trading day is expected to be 33.07 with a mean absolute deviation of 0.43 and the sum of the absolute errors of 25.55. Teva Pharma after-hype prediction price | USD 33.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Teva Pharma to cross-verify your projections. Teva Pharma Additional Predictive Modules
Most predictive techniques to examine Teva price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Teva using various technical indicators. When you analyze Teva charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Teva Pharma Simple Exponential Smoothing Price Forecast For the 31st of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Teva Pharma Industries on the next trading day is expected to be 33.07 with a mean absolute deviation of 0.43, mean absolute percentage error of 0.51, and the sum of the absolute errors of 25.55.Please note that although there have been many attempts to predict Teva Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Teva Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Teva Pharma Stock Forecast Pattern
| Backtest Teva Pharma | Teva Pharma Price Prediction | Buy or Sell Advice |
Teva Pharma Forecasted Value
In the context of forecasting Teva Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Teva Pharma's downside and upside margins for the forecasting period are 30.07 and 36.07, respectively. We have considered Teva Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Teva Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Teva Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.596 |
| Bias | Arithmetic mean of the errors | -0.2092 |
| MAD | Mean absolute deviation | 0.4258 |
| MAPE | Mean absolute percentage error | 0.0153 |
| SAE | Sum of the absolute errors | 25.55 |
Predictive Modules for Teva Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Teva Pharma Industries. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Teva Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Teva Pharma After-Hype Price Density Analysis
As far as predicting the price of Teva Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Teva Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Teva Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Teva Pharma Estimiated After-Hype Price Volatility
In the context of predicting Teva Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Teva Pharma's historical news coverage. Teva Pharma's after-hype downside and upside margins for the prediction period are 30.07 and 36.07, respectively. We have considered Teva Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Teva Pharma is very steady at this time. Analysis and calculation of next after-hype price of Teva Pharma Industries is based on 3 months time horizon.
Teva Pharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Teva Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Teva Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Teva Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.83 | 3.00 | 0.11 | 0.04 | 7 Events / Month | 2 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
33.07 | 33.07 | 0.00 |
|
Teva Pharma Hype Timeline
Teva Pharma Industries is at this time traded for 33.07. The entity has historical hype elasticity of -0.11, and average elasticity to hype of competition of 0.04. Teva is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.83%. %. The volatility of related hype on Teva Pharma is about 6250.0%, with the expected price after the next announcement by competition of 33.11. About 59.0% of the company shares are owned by institutional investors. The book value of Teva Pharma was at this time reported as 6.88. The company has Price/Earnings To Growth (PEG) ratio of 1.29. Teva Pharma Industries last dividend was issued on the 27th of November 2017. The entity had 2:1 split on the 1st of July 2004. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Historical Fundamental Analysis of Teva Pharma to cross-verify your projections.Teva Pharma Related Hype Analysis
Having access to credible news sources related to Teva Pharma's direct competition is more important than ever and may enhance your ability to predict Teva Pharma's future price movements. Getting to know how Teva Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Teva Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BIIB | Biogen Inc | 0.00 | 0 per month | 1.69 | 0.11 | 2.91 | (2.55) | 9.61 | |
| STE | STERIS plc | (0.13) | 11 per month | 1.04 | 0.08 | 1.91 | (1.58) | 10.91 | |
| DXCM | DexCom Inc | (0.13) | 11 per month | 1.52 | 0.15 | 3.29 | (2.78) | 8.87 | |
| BNTX | BioNTech SE | 0.74 | 11 per month | 2.06 | 0.05 | 3.28 | (3.16) | 13.89 | |
| NTRA | Natera Inc | 0.00 | 0 per month | 1.66 | 0.12 | 3.54 | (2.21) | 10.60 | |
| PODD | Insulet | 0.00 | 0 per month | 0.00 | (0.17) | 3.24 | (3.62) | 13.53 | |
| LH | Laboratory of | 0.00 | 0 per month | 1.04 | 0.02 | 2.71 | (1.98) | 5.89 | |
| WAT | Waters | 0.00 | 0 per month | 0.92 | 0.05 | 3.35 | (1.83) | 8.85 | |
| PHG | Koninklijke Philips NV | 0.00 | 0 per month | 1.63 | 0.04 | 2.53 | (1.96) | 8.74 | |
| NBIX | Neurocrine Biosciences | 0.00 | 0 per month | 0.00 | (0.05) | 2.38 | (3.43) | 12.11 |
Other Forecasting Options for Teva Pharma
For every potential investor in Teva, whether a beginner or expert, Teva Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Teva Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Teva. Basic forecasting techniques help filter out the noise by identifying Teva Pharma's price trends.Teva Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Teva Pharma stock to make a market-neutral strategy. Peer analysis of Teva Pharma could also be used in its relative valuation, which is a method of valuing Teva Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Teva Pharma Market Strength Events
Market strength indicators help investors to evaluate how Teva Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Teva Pharma shares will generate the highest return on investment. By undertsting and applying Teva Pharma stock market strength indicators, traders can identify Teva Pharma Industries entry and exit signals to maximize returns.
Teva Pharma Risk Indicators
The analysis of Teva Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Teva Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting teva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.6 | |||
| Semi Deviation | 0.367 | |||
| Standard Deviation | 3.0 | |||
| Variance | 9.02 | |||
| Downside Variance | 1.45 | |||
| Semi Variance | 0.1347 | |||
| Expected Short fall | (2.09) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Teva Pharma
The number of cover stories for Teva Pharma depends on current market conditions and Teva Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Teva Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Teva Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Check out Historical Fundamental Analysis of Teva Pharma to cross-verify your projections. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Teva Pharma assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Teva Pharma Industries requires distinguishing between market price and book value, where the latter reflects Teva's accounting equity. The concept of intrinsic value—what Teva Pharma's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Teva Pharma's price substantially above or below its fundamental value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Teva Pharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.